1. Home
  2. ATNM vs GMM Comparison

ATNM vs GMM Comparison

Compare ATNM & GMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.43

Market Cap

50.2M

Sector

Health Care

ML Signal

HOLD

Logo Global Mofy Metaverse Limited

GMM

Global Mofy Metaverse Limited

N/A

Current Price

$1.31

Market Cap

39.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ATNM
GMM
Founded
2000
2017
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.2M
39.6M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
ATNM
GMM
Price
$1.43
$1.31
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
194.8K
15.6K
Earning Date
11-14-2025
08-18-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.79
Revenue
$90,000.00
$48,171,048.00
Revenue This Year
N/A
N/A
Revenue Next Year
$42,943.57
N/A
P/E Ratio
N/A
$0.75
Revenue Growth
11.11
41.74
52 Week Low
$1.03
$1.23
52 Week High
$2.41
$4.97

Technical Indicators

Market Signals
Indicator
ATNM
GMM
Relative Strength Index (RSI) 51.02 28.88
Support Level $1.33 $1.25
Resistance Level $1.54 $1.59
Average True Range (ATR) 0.09 0.09
MACD 0.01 -0.01
Stochastic Oscillator 56.90 22.01

Price Performance

Historical Comparison
ATNM
GMM

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About GMM Global Mofy Metaverse Limited

Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.

Share on Social Networks: